well I have had a conservative value of between 3.00-5.00 a share just on the legal deal alone, that valuation does not include any sales I am not disputing your figures my understanding is currently bta reliant on gsk to deliver the sales and revenue there is only royalties of 7% however hopefully bta get a different deal on the new drugs as 7% seems pitiful compared to the expertise in finding the solution they should get a better deal to share in the profits cheers
BTA Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
